• Sophia Genetics Chief Legal Officer Daan van Well sold 1,411 Ordinary Shares on November 9, 2026.
• The sale price was $7.4355 per share, leaving direct beneficial ownership of 331,305 Ordinary Shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001840706-26-000356), on November 12, 2026, and is solely responsible for the information contained therein.